c-kit+AT2R+Bone Marrow Mononuclear Cell Subset Is a Superior Subset for Cardiac Protection after Myocardial Infarction
Open Access
- 1 January 2016
- journal article
- Published by Hindawi Limited in Stem Cells International
- Vol. 2016, 1-15
- https://doi.org/10.1155/2016/4913515
Abstract
Although the bone marrow mononuclear cell (BMMNC) is known as an ideal cell type for cell-based therapy for MI treatment, the effective subpopulation still remains unknown. Our study aimed at identifying the optimal subset of BMMNCs suited for cardiac regeneration. In this study, we observed that MI led to (i) a significant increase of the c-kit+AT2R+BMMNC subpopulation in mice and (ii) a modest increase of AT2R+BMMNCs in humans. c-kit+AT2R+and c-kit+AT2R−BMMNC subpopulations were obtained from mice after MI. Then, we cocultured cardiac H9C2 cells with c-kit+AT2R+, c-kit+AT2R−, and unfractionated BMMNCs; finally, we found that the c-kit+AT2R+subset is superior to the c-kit+AT2R−subset in improving cardiomyocyte protection in vitro. Of note, c-kit+AT2R+BMMNCs showed a more robust migration capacity than c-kit+AT2R−and unfractionated BMMNCsin vitroandin vivo. Additionally, compared to c-kit+AT2R−and unfractionated BMMNCs, intravenous transplantation of c-kit+AT2R+BMMNC resulted in smaller infarct size and lower levels of inflammatory reactions in heart tissue, leading to a higher global heart function improvement. In conclusion, our results indicate that the c-kit+AT2R+BMMNC subpopulation exerts a protective effect against MI and shows promising therapeutic possibilities with regard to the treatment of ischemic heart disease.Keywords
Funding Information
- National Natural Science Foundation of China (81300088, 14YZ031, 124119a2100, YG2014ZD02, YG2013MS38)
This publication has 32 references indexed in Scilit:
- Bone-Derived Stem Cells Repair the Heart After Myocardial Infarction Through Transdifferentiation and Paracrine Signaling MechanismsCirculation Research, 2013
- Bone marrow mononuclear cells and acute myocardial infarctionStem Cell Research & Therapy, 2012
- Treatment of Human Mesenchymal Stem Cells with Angiotensin Receptor Blocker Improved Efficiency of Cardiomyogenic Transdifferentiation and Improved Cardiac Function via AngiogenesisThe International Journal of Cell Cloning, 2011
- Isolated Coronary Artery Bypass Graft Combined With Bone Marrow Mononuclear Cells Delivered Through a Graft Vessel for Patients With Previous Myocardial Infarction and Chronic Heart Failure: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical TrialJournal of the American College of Cardiology, 2011
- Identification of Noncytotoxic and IL-10–Producing CD8+AT2R+ T Cell Population in Response to Ischemic Heart InjuryThe Journal of Immunology, 2010
- Angiotensin II bi-directionally regulates cyclooxygenase-2 expression in intestinal epithelial cellsMolecular and Cellular Biochemistry, 2008
- Stem cell factor-mediated activation pathways promote murine eosinophil CCL6 production and survivalJournal of Leukocyte Biology, 2007
- Marrow Stromal Cells Transplanted to the Adult Brain Are Rejected by an Inflammatory Response and Transfer Donor Labels to Host Neurons and GliaThe International Journal of Cell Cloning, 2006
- Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokinesJCI Insight, 2006
- Nitric Oxide Mediates Benefits of Angiotensin II Type 2 Receptor Overexpression During Post-Infarct RemodelingHypertension, 2004